Skip to content
Medical Health Aged Care

Stem Cells: Hope on the Horizon for Preterm Babies

Monash University 3 mins read

Australian researchers have discovered a potential new lifeline for the tiniest and most vulnerable newborns. Scientists at Monash Children's Hospital have successfully collected and reinfused umbilical cord blood cells in extremely premature babies, offering a glimmer of hope for preventing brain injuries.

This pioneering Australian research, undertaken by a collaboration of Monash Health’s Monash Children’s Hospital, The School of Clinical Sciences at Monash University, and Hudson Institute of Medical Research, has successfully demonstrated the feasibility and safety of using a baby's own cord blood-derived cells as a potential treatment for extremely preterm infants.

 

Published in the Lancet journal eBioMedicine, this breakthrough offers new possibilities for the more than 3000 very preterm infants born in Australia each year before 32 weeks' gestation.

 

A Delicate Process

 

The Cord-Safe Study focused on infants born before 28 weeks of pregnancy - babies so small they could fit in the palm of your hand. Collecting cord blood from extremely preterm infants is no small feat. With smaller placentas, minimal blood volumes, and complex delivery circumstances, researchers face significant challenges in gathering these precious cells.

 

Despite these obstacles, the team managed to successfully collect and process cord blood cells from approximately 70 per cent of the extremely premature infants enrolled in the study.

 

Importantly, the study showed that 23 extremely preterm infants received cord blood-derived cell infusions with no serious adverse events reported, confirming that the procedure is safe and tolerable in this vulnerable population.

 

This world-first phase-1 clinical trial has now demonstrated that umbilical cord blood derived cell (UCBC) collection and reinfusion is not only feasible but also well-tolerated in these vulnerable babies.

 

Why It Matters

 

Premature babies are at high risk of brain injuries that can lead to lifelong challenges like cerebral palsy. By using their own cord blood cells, researchers believe they might be able to provide a natural "protective shield" for these vulnerable infants' developing brains.

 

"This research represents an exciting development in neonatal care," said Dr Lindsay Zhou, Neonatologist and study lead author. "For the first time, we're exploring how a baby's own cord blood cells might be used therapeutically in extremely preterm infants, offering a potential treatment option where previously there were limited alternatives."

 

The study builds on substantial preclinical evidence showing that umbilical cord blood-derived cells can be neuroprotective for the preterm brain. These cells have demonstrated multiple beneficial effects, including anti-inflammatory, immunomodulatory and protective mechanisms for the developing brain.

 

Looking Ahead

 

The success of this feasibility study paves the way for larger international trials. As cell therapies are increasingly being evaluated for neuroprotection and neuroregeneration in young children, this research positions Australia at the forefront of innovative neonatal care.

 

The project’s lead researcher, Associate Professor Atul Malhotra said this breakthrough offered a beacon of hope for parents and medical professionals dealing with the complex challenges of extremely premature birth, potentially changing the landscape of neonatal care for generations to come.


"The Cord-Safe Study represents a crucial step in exploring how we can use a baby's own cord blood to improve outcomes," Associate Professor Malhotra said. "By forming the basis for an international randomised controlled trial, this study highlights Australia's leadership in developing innovative treatments in neonatal care."

 

History: Previous work by Associate Professor Malhotra and team showed feasibility of collection of cord blood in extremely preterm babies. Access here


For media enquiries please contact:

 

Monash Health: 

E: media@monashhealth.org
T: +61 (0) 03 9594 7722

 

Monash University:
E: 
media@monash.edu
T: +61 (0) 3 9903 4840

 

For more Monash media stories, visit our news and events site 

 

 

***ENDS***

 

Media

More from this category

  • Medical Health Aged Care
  • 16/01/2025
  • 16:26
King Faisal Specialist Hospital & Research Centre

KFSH&RC Celebrates 25 Scientists Named in Stanford’s Top 2% Most-Cited Researchers Worldwide

RIYADH, Saudia Arabia, Jan. 16, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre honored 25 scientists who joined Stanford University's prestigious list, marking them among the 'top 2% most-cited scientists' list updated in October 2023.The recent release recognizes 25 distinguished KFSH&RC scientists, among the top 2% most-cited researchers worldwide in 2021-2022, and acknowledges their overall career accomplishments. This prestigious recognition celebrates the outstanding contributions and impact of KFSH&RC researchers on the global scientific stage, highlighting KFSH&RC's steady commitment to advancing healthcare through novel research. It elevates its international reputation as a pioneer hub for innovative research.His Excellency…

  • Medical Health Aged Care
  • 16/01/2025
  • 08:41
Mainstay Medical Holdings plc

Mainstay Medical Announces Positive Outcomes from Landmark RESTORE Clinical Trial of ReActiv8®

ReActiv8® Restorative NeurostimulationTM demonstrated statistically significant and clinically meaningful superiority vs. standard of care in all primary and secondary measures of disability, pain and…

  • Contains:
  • Medical Health Aged Care
  • 16/01/2025
  • 06:05
Royal Australian College of GPs

ADHD reform more urgent in NSW with psychiatrists’ workforce crisis

The Royal Australian College of GPs is urging the New South Wales Government to prioritise reforms to improve access to support and treatment for people with attention deficit hyperactivity disorder (ADHD) from GPs after the mass resignation of psychiatrists. Around 200 psychiatrists in NSW's public health system have submitted their resignations amid an ongoing pay dispute with the state government. RACGP New South Wales Chair Dr Rebekah Hoffman said: “GPs should be able to initiate and prescribe medications for people living with ADHD, and manage their care. Allowing GPs to give more support to people living with ADHD will improve…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.